PCA3 in the detection and management of early prostate cancer.
about
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travelProstate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersGenome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experienceClinical significance of NUCB2 mRNA expression in prostate cancer.Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Molecular markers to guide primary radical treatment selection in localized prostate cancer.Long noncoding RNAs in liver cancer: what we know in 2014.Prostate cancer: a review of active surveillance.Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.Current biomarkers for diagnosing of prostate cancer.Long noncoding RNAs in lung cancer: what we know in 2015.Risk stratification of prostate cancer 2016.Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells.Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?Emerging biomarkers in the diagnosis of prostate cancer.
P2860
Q27001399-CAE1BB5E-3A8E-4970-A933-478FDA564419Q28075610-2B59B602-B6BC-4049-8501-BDE0165B170CQ33568125-67FA9C05-E876-4C5A-A1EC-804387EAE2B6Q35074229-E3E6520A-4318-4E06-A086-B9C3771F9E4FQ37116462-5C958F48-A7A0-4180-9770-F55F2E212919Q37155070-5F6E2A60-BB5D-42C3-AB79-05041EFDB692Q37367755-B4F82071-C3C9-4829-B8DC-E69B783E344AQ37644685-EBDD505E-8255-40F7-90E9-3B39D235EAEDQ38216129-5BDD8679-2639-4DE6-90D6-66388C32655CQ38226242-6F867435-D1A1-42AB-AAFD-F2FF9DD1F038Q38241983-1BE946A0-7CAA-4F5F-B8DC-26A13D7E8387Q38247297-8F388788-D4F6-43C7-81EE-61AEDCA65B96Q38568275-A20DEE6C-BE99-4076-BF1B-B099C4F6E467Q38584370-04C56332-16CA-41B0-B84E-0F96BCD1D40FQ38672942-9A5BD4E2-C5E1-47A8-8BB3-3C8B624B5852Q38929868-85D604F9-76A1-478C-8964-D331528A2BB3Q41808633-668C8FEB-15E6-4637-8A40-B47CAAB9A4C4Q48225109-AE7A153A-D8C5-498E-BEF4-EFF52A87F59DQ54964875-0E0BAB8A-B9DA-4AF2-AEA7-EA4DB8EA97A3
P2860
PCA3 in the detection and management of early prostate cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
PCA3 in the detection and management of early prostate cancer.
@en
type
label
PCA3 in the detection and management of early prostate cancer.
@en
prefLabel
PCA3 in the detection and management of early prostate cancer.
@en
P2093
P2860
P1433
P1476
PCA3 in the detection and management of early prostate cancer.
@en
P2093
Josep M Augé
Montserrat Milà
Rafael Molina
Wladimiro Jiménez
Xavier Filella
P2860
P2888
P304
P356
10.1007/S13277-013-0739-6
P577
2013-03-16T00:00:00Z
P6179
1028433189